Back

DCM and ARVC all in one: the paradigm of phospholamban

17 April 2023 (18:30 - 18:45)
Organised by:
Congress Presentation Part of: Non ischaemic dilated cardiomyopathy: genotype specific management Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Cristina Basso

University of Padua, Padova (Italy)

3 More presentations in this session

Presentation thumbnail
What not to miss: the importance of laminopathy
Doctor N. Hasselberg (Oslo, NO)
Slides
Presentation thumbnail
The commonest entity in DCM: titin
Professor L. Mestroni (Aurora, US)
Slides
Presentation thumbnail
When does channelopathy cause DCM: the dark side of the sodium channel
Associate Professor C. Remme (Amsterdam, NL)
Slides

Access the full session

Session thumbnail
Non ischaemic dilated cardiomyopathy: genotype specific management

The Event

Event poster

EHRA 2023

17 April 2023 18:30 CET
You may be interested in
thumbnail
Congress Presentation
Guideline-directed approach to diagnosing phospholamban-related arrhythmogenic left ventricular cardiomyopathy
10 May 2026
thumbnail
Congress Presentation
Impaired autophagy mechanisms associated with phospholamban-R14del disease
12 April 2024
thumbnail
Congress Presentation
REALM-DCM: a phase 3, multinational, randomized, placebo-controlled study of ARRY-371797 (PF-07265803) in patients with symptomatic LMNA-related dilated cardiomyopathy
20 May 2023
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources